Literature DB >> 19678836

Macrocypins, a family of cysteine protease inhibitors from the basidiomycete Macrolepiota procera.

Jerica Sabotic1, Tatjana Popovic, Vida Puizdar, Joze Brzin.   

Abstract

A new family of cysteine protease inhibitors from the basidiomycete Macrolepiota procera has been identified and the family members have been termed macrocypins. These macrocypins are encoded by a family of genes that is divided into five groups with more than 90% within-group sequence identity and 75-86% between-group sequence identity. Several differences in the promoter and noncoding sequences suggest regulation of macrocypin expression at different levels. High yields of three different recombinant macrocypins were produced by bacterial expression. The sequence diversity was shown to affect the inhibitory activity of macrocypins, the heterologously expressed macrocypins belonging to different groups showing differences in their inhibitory profiles. Macrocypins are effective inhibitors of papain and cysteine cathepsin endopeptidases, and also inhibit cathepsins B and H, which exhibit both exopeptidase and endopeptidase activities. The cysteine protease legumain is inhibited by macrocypins with the exception of one representative that exhibits, instead, a weak inhibition of serine protease trypsin. Macrocypins exhibit similar basic biochemical characteristics, stability against high temperature and extremes of pH, and inhibitory profiles similar to those of clitocypin from Clitocybe nebularis, the sole representative of the I48 protease inhibitor family in the merops database. This suggests that they belong to the same merops family of cysteine protease inhibitors, the mycocypins, and substantiates the establishment of the I48 protease inhibitor family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19678836     DOI: 10.1111/j.1742-4658.2009.07138.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

1.  Structural basis of trypsin inhibition and entomotoxicity of cospin, serine protease inhibitor involved in defense of Coprinopsis cinerea fruiting bodies.

Authors:  Jerica Sabotič; Silvia Bleuler-Martinez; Miha Renko; Petra Avanzo Caglič; Sandra Kallert; Borut Štrukelj; Dušan Turk; Markus Aebi; Janko Kos; Markus Künzler
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Bivalent carbohydrate binding is required for biological activity of Clitocybe nebularis lectin (CNL), the N,N'-diacetyllactosediamine (GalNAcβ1-4GlcNAc, LacdiNAc)-specific lectin from basidiomycete C. nebularis.

Authors:  Jure Pohleven; Miha Renko; Špela Magister; David F Smith; Markus Künzler; Borut Štrukelj; Dušan Turk; Janko Kos; Jerica Sabotič
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

3.  Versatile loops in mycocypins inhibit three protease families.

Authors:  Miha Renko; Jerica Sabotic; Marko Mihelic; Joze Brzin; Janko Kos; Dusan Turk
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

Review 4.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

5.  Structural and functional studies of legumain-mycocypin complexes revealed a competitive, exosite-regulated mode of interaction.

Authors:  Tasneem Elamin; Naiá P Santos; Peter Briza; Hans Brandstetter; Elfriede Dall
Journal:  J Biol Chem       Date:  2022-09-15       Impact factor: 5.486

6.  Cocaprins, β-Trefoil Fold Inhibitors of Cysteine and Aspartic Proteases from Coprinopsis cinerea.

Authors:  Miha Renko; Tanja Zupan; David F Plaza; Stefanie S Schmieder; Milica Perišić Nanut; Janko Kos; Dušan Turk; Markus Künzler; Jerica Sabotič
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

7.  Fungal lectin MpL enables entry of protein drugs into cancer cells and their subcellular targeting.

Authors:  Simon Å Urga; Milica Perišić Nanut; Janko Kos; Jerica Sabotič
Journal:  Oncotarget       Date:  2017-04-18

Review 8.  Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease.

Authors:  Namdoo Kim; Hyuck Jin Lee
Journal:  Biomed Res Int       Date:  2020-11-09       Impact factor: 3.411

Review 9.  Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.

Authors:  Livija Tušar; Aleksandra Usenik; Boris Turk; Dušan Turk
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

Review 10.  CNL-Clitocybe nebularis Lectin-The Fungal GalNAcβ1-4GlcNAc-Binding Lectin.

Authors:  Jerica Sabotič; Janko Kos
Journal:  Molecules       Date:  2019-11-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.